Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator. Requirement for a co-receptor?

Thrombosis and Haemostasis

Volumn 83, Issue 2, 2000, Pages 290-296

  Camani, Chantal ^b   Gavin, Olivier ^b   Kruithof, Egbert K O ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

Clearance; LRP; PAI 1; T PA; Thrombin

Indexed keywords

CHLORATE; GLYCOSAMINOGLYCAN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASE NEXIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL LINE; COMPLEX FORMATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

EID: 0033974308     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613801     Document Type: Article

References (30)

1. Otter M, Barrett-Bergshoeff MM, Rijken DC. Binding of tissue-type plasminogen activator by the mannose receptor. J Biol Chem 1991; 266: 13931-5.
2. Narita M, Bu G, Herz J, Schwartz AL. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo. J Clin Invest 1995; 96: 1164-8.
3. Biessen EA, Van Teijlingen M, Vietsch H, Barrett-Bergshoeff MM, Bijsterbosch MK, Rijken DC, Van Berkel TJ, Kuiper J. Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator. Circulation 1997; 95: 46-52.
4. Wing LR, Hawksworth GM, Bennett B, Booth, NA. Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system. J Lab Clin Med 1991; 117: 109-14.
5. Camani C, Bachmann F, Kruithof EKO. The role of plasminogen activator inhibitor type I in the clearance of tissue-type plasminogen activator by rat hepatoma cells. J Biol Chem 1994; 269: 5770-5.
6. Horn IR, Van den Berg BMM, Van der Meijden PZ, Pannekoek H, Van Zonneveld AJ. Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. J Biol Chem 1997; 272: 13608-13.
7. 2-macroglobulin receptor containing a cluster of eight complement-type repeats. J Biol Chem 1993; 268: 13691-6.
8. Willnow TE, Orth K, Herz J. Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein. J Biol Chem 1994; 269: 15827-32.
9. 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci USA 1992; 89: 7427-31.
10. 2-macroglobulin receptor. Proc Natl Acad Sci USA 1992; 89: 7422-6.
11. Andreasen PA, Sottrup-Jensen L, Kjøller L, Nykjaer A, Moestrup SK, Petersen CM, Gliemann J. Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes. FEBS Lett 1994; 338: 239-45.
12. 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands. Biochim Biophys Acta 1994; 1197: 197-213.
13. 2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein. Eur J Biochem 1997; 248: 270-81.
14. 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. J Biol Chem 1993; 268: 21862-7.
15. Stefansson S, Kounnas MZ, Henkin J, Mallampalli RK, Chappell DA, Strickland DK, Argraves WS. gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex. J Cell Sci 1995; 108: 2361-8.
16. 2-macroglobulin receptor/low density lipoprotein receptor-related protein. J Biol Chem 1994; 269: 25668-76.
17. Kounnas MZ, Chappell DA, Wong H, Argraves WS, Strickland DK. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J Biol Chem 1995; 270: 9307-12.
18. Knauer MF, Kridel SJ, Hawley SB, Knauer DJ. The efficient catabolism of thrombin-protease nexin 1 complexes is a synergistic mechanism that requires both the LDL receptor-related protein and cell surface heparins. J Biol Chem 1997; 272: 29039-45.
19. 2-macroglobulin receptor. J Biol Chem 1991; 266: 21232-8.
20. Fraker PJ, Speck JC Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-57.
21. Esko JD, Stewart TE, Taylor WH. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci USA 1985; 82: 3197-201.
22. 2-macroglobulin receptor (low density lipoprotein receptor-related protein). J Biol Chem 1991; 266: 14011-7.
23. Montgomery RI, Lidholt K, Flay NW, Liang J, Vertel B, Lindahl U, Esko JD. Stable heparin-producing cell lines derived from the Furth murine mastocytoma. Proc Natl Acad Sci USA 1992; 89: 11327-31.
24. Camani C, Gavin O, Bertossa C, Samatani E, Kruithof EKO. Studies on the effect of fucosylated and non-fucosylated finger/growth factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein. Eur J Biochem 1998; 251: 804-11.
25. 2-macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor. J Cell Biol 1995; 131: 1609-22.
26. 2-macroglobulin synthesis by the human monocytic cell line THP-1 is differentiation state-dependent. J Cell Biochem 1997; 67: 492-7.
27. Nykjaer A, Conese M, Christensen EI, Olson D, Cremona O, Gliemann J, Blasi F. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J 1997; 16: 2610-20.
28. Nykjaer A, Christensen EI, Vorum H, Hager H, Petersen CM, Røigaard H, Min HY, Vilhardt F, Møller LB, Kornfeld S, Gliemann J. Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J Cell Biol 1998; 141: 815-28.
29. Fischer B. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin. Biomed Biochim Acta 1991; 50: 47-54.
30. Böhm T, Geiger M, Binder BR. Isolation and characterization of tissue-type plasminogen activator-binding proteoglycans from human umbilical vein endothehal cells. Arterioseler Thromb Vase Biol 1996; 16: 665-72.